Avanos Medical, Inc. (AVNS)
NYSE: AVNS · Real-Time Price · USD
13.69
+0.26 (1.94%)
At close: Mar 13, 2026, 4:00 PM EDT
13.72
+0.03 (0.22%)
After-hours: Mar 13, 2026, 7:00 PM EDT

Avanos Medical Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
6375227321,0361,2591,671
Market Cap Growth
-11.41%-28.70%-29.35%-17.74%-24.66%-23.98%
Enterprise Value
675.93542.61773.931,1361,3901,726
Last Close Price
13.6911.2315.9222.4327.0634.67
PE Ratio
--7.15-1.87-16.9925.29-54.17
Forward PE
13.6911.7010.1015.6515.8923.16
PEG Ratio
-4.394.392.340.891.30
PS Ratio
0.910.741.061.541.842.85
PB Ratio
0.820.670.880.840.981.32
P/TBV Ratio
0.820.670.880.850.991.33
P/FCF Ratio
14.7712.108.8370.9417.5825.21
P/OCF Ratio
8.526.987.2731.9713.8519.14
EV/Sales Ratio
0.960.771.131.692.032.94
EV/EBITDA Ratio
12.43-23.90-2.2122.5816.71-2465.15
EV/EBIT Ratio
43.61-8.81-1.95270.4039.16-44.25
EV/FCF Ratio
15.6812.599.3477.7919.4226.03
Debt / Equity Ratio
0.140.140.180.150.200.14
Debt / EBITDA Ratio
-1.33-5.69-0.484.163.33-267.86
Debt / FCF Ratio
3.003.002.0514.323.872.83
Net Debt / Equity Ratio
0.050.050.080.100.120.05
Net Debt / EBITDA Ratio
-0.40-1.73-0.182.411.79-98.57
Net Debt / FCF Ratio
0.910.910.758.322.091.04
Asset Turnover
0.630.630.480.390.400.36
Inventory Turnover
2.422.422.031.991.991.75
Quick Ratio
1.171.171.450.981.551.79
Current Ratio
2.152.152.372.083.273.07
Return on Equity (ROE)
-9.07%-9.07%-37.42%-0.78%1.68%-2.45%
Return on Assets (ROA)
-12.93%-6.09%-26.66%0.30%1.69%-1.75%
Return on Invested Capital (ROIC)
-16.58%-7.81%-32.21%0.36%2.00%-2.07%
Return on Capital Employed (ROCE)
-14.35%-6.50%-32.39%0.28%2.32%-2.63%
Earnings Yield
-11.45%-13.98%-53.58%-5.88%3.95%-1.85%
FCF Yield
6.77%8.26%11.33%1.41%5.69%3.97%
Buyback Yield / Dilution
0.50%0.50%1.60%1.72%3.48%0.32%
Updated Feb 24, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q